Category list : Asthma
Sort by: Newest first Oldest first A-Z Z-A
-
Top ten opinion pieces of 2020
Our news and views team has worked hard to keep you in the loop during a year full of twists and turns. And there’s been no shortage of COVID-19 developments for our opinion leaders to analyse, or pharmacy predictions to ponder.
-
Personalised medicine approach could benefit people with asthma Subscription
Prescribing asthma treatment based on genetic differences could improve outcomes, results presented at the European Respiratory Society International Congress have suggested.
-
Novel once-daily fixed-dose ICS–LABA improves lung function over ICS monotherapy, research finds Subscription
A once-daily fixed-dose combination of inhaled corticosteroids and long-acting β2-adrenoceptor agonist significantly improved lung function over inhaled corticosteroids alone, a phase III study has concluded.
-
Once-daily ICS-LABA-LAMA superior to ICS-LABA in improving lung function, research suggests Subscription
A study in The Lancet Respiratory Medicine indicates that ICS-LABA-LAMA once daily is better than ICS-LABA in improving lung function.
-
Reducing asthma medication does not worsen outcomes but could save money, study suggests Subscription
Stepping down asthma medication does not adversely affect patient outcomes and could save millions of pounds in medicines costs, a study in PLoS Medicine has found.
-
Inhaler recycling scheme that cut carbon emissions equivalent to more than 8,500 cars is scrapped Subscription
A scheme to recycle respiratory inhalers, which has cut carbon dioxide emissions equivalent to taking around 8,600 cars off UK roads, is ending.
-
Blue, brown and now green Subscription
The ‘NHS long-term plan’ has called for a shift towards inhalers with a lower carbon footprint.
-
Salbutamol inhaler prescribing jumped 60% at start of COVID-19 pandemic
The number of some inhalers prescribed by GPs in England increased by 63% between February 2020 and March 2020, according to data analysed by The Pharmaceutical Journal.
-
Why we must urgently rethink prescribing short-acting bronchodilators for asthma Subscription
Guidelines from the Global Initiative for Asthma present a radical overhaul of the way we manage asthma; but our current approach isn’t working, and nothing will change if it is not challenged.
-
Asthma exacerbations during pregnancy linked to birth complications Subscription
Women with asthma who experience exacerbations during pregnancy are more likely to have birth complications than women with well-controlled asthma, a study published in the European Respiratory Journal has suggested.
-
Top ten most popular opinion articles of 2019
The Pharmaceutical Journal wasn’t short of strong views this year — whether it was a criticism of clinical guidance or a defence of the pharmacy profession. Here are the opinions that resonated most with you in 2019.
-
Community pharmacy service improves inhaler technique, study shows Subscription
Dedicated community pharmacy services can improve inhaler technique for almost all patients, a study presented at the British Thoracic Society Winter Meeting has shown.
-
Switching from MDIs could reduce carbon impact of inhalers and save money Subscription
Switching patients who use metered-dose inhalers, which contain hydrofluoroalkane propellants, to cheaper, more environmentally friendly alternatives could lead to major cost savings, as well as reduced NHS greenhouse gas emissions.
-
It's not just medicines that improve health — pharmacists need a better understanding of nutrition Subscription
Research shows that dietary changes can help to manage conditions such as diabetes and asthma, so undergraduate pharmacy courses must better prepare pharmacists to advise patients on healthy eating behaviours.
-
Triple-therapy inhaler improves lung function in adults with asthma Subscription
Combining three therapies into one inhaler improves lung function and reduces exacerbations in adults with uncontrolled asthma, researchers have concluded in a paper published in The Lancet.
-
First reusable, propellant-free inhaler launched to cut plastic waste
The first reusable, propellant-free inhaler is now available for patients with asthma and COPD, in line with NHS plans to reduce its carbon footprint and plastic waste.
-
Switching inhalers can boost adherence Subscription
Inhaler switching in asthma and COPD is not associated with negative impacts on patients’ health, study results published in Thorax have shown.
-
Unclear guidelines mean four in five patients with severe asthma do not get proper care
Some four out of five people in England with severe asthma are not getting the care they need as a result of unclear clinical guidelines, a report by Asthma UK has said.
-
Asthma deaths in the UK reach a ten-year high
Deaths from asthma in England and Wales are the highest they have been in the past decade, an analysis of data from the Office for National Statistics by the charity Asthma UK has shown.
-
Biologic injection for severe asthma approved in Scotland
A biologic injection intended for the treatment of severe eosinophilic asthma has been accepted for restricted use by the Scottish Medicines Consortium, providing another option for patients who fail to respond to other treatments.
